Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group

About this trial

IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the study is to explore infant feeding preferences, practices, and outcomes among mothers with HIV and their families in the United States. It will employ both qualitative and quantitative research methods to address existing knowledge gaps and to understand the clinical, behavioral, and social factors influencing infant feeding decisions. As part of the study's mixed method approach, a longitudinal cohort study of mothers and their infants will be established. The study also aims to pilot a national registry of breastfeeding women living with HIV in the United States.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Is of legal age or circumstance to provide independent informed consent

Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is considering breastfeeding

Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is not considering breastfeeding

Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, did not breastfeed for any duration and has no intent to breastfeed

Disqualifiers

Has any condition identified during the screening period that, in the opinion of site investigator, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

Trial population

Pregnant and postpartum women with HIV (PPWH); healthcare providers (HCP) and ancillary healthcare professionals (AHP) who care for PPWH and/or their infants; other influential individuals who contribute to infant feeding decisions. Pilot registry testers who will enter data into the pilot registry.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No intervention provided in this study

    Other intervention

    None; No intervention provided in this study

Treatment groups

1,150 Participants
are divided into 3 treatment groups
Group A: Core Activity 11 intervention
Group B: Core Activity 21 intervention
Group C: Core Activity 31 intervention

Trial outcomes

Primary outcomes

1

CA 1: Factors influencing infant feeding decision

Qualitative themes from in-depth interviews

Time frame
Within 28 days and 2 years of Enrollment
2

CA 1: Infants born to women with HIV who receive any breast milk

Binomial outcome from site level surveys

Time frame
Monthly, through study completion, up until 5 years
3

CA 2: Infant feeding method chosen

Binary outcome

Time frame
At 48 weeks post birth
4

CA 2: Breastfeeding initiation among those who intended to breastfeed

Binary outcome

Time frame
At 48 weeks post birth

Secondary outcomes

1

CA 1: Approaches to support infant feeding decisions and improve quality of care

Qualitative themes from in-depth interviews

Time frame
Within 28 days and 2 years of Enrollment
2

CA 1: Descriptive results of current practices, burden, benefits and resources

Site surveys, provider surveys, In-depth Interviews

Time frame
Monthly, through study completion, up to 5 years
3

CA 2: Median cost per postpartum woman with HIV and infant pair

Numerical outcome, by feeding approach

Time frame
Through study completion, up to 5 years
4

CA 2: Cost effectiveness ratio presented as cost per quality adjusted life year saved in breastfeeding mother/infant pair

Numerical outcome

Time frame
Through study completion, up to 5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Lead sponsor

University of Colorado, Denver

Collaborator

Centers for Disease Control and Prevention

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator